Momenta, Sandoz Ask Justices To Clarify Safe Harbor Rule
By Ben James ( March 1, 2013, 7:15 PM EST) -- Momenta Pharmaceuticals Inc. and Sandoz Inc. have urged the U.S. Supreme Court to review a ruling that lifted an injunction blocking sales of a generic version of blood thinner Lovenox and to clarify the scope of the Hatch-Waxman Act's safe harbor provision....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.